Navigation Links
CME on atrial fibrillation, interventional cardiology and lipids online at CardioCareLive

Boston, MA May 24, 2010 CardioCareLive, the world's largest live online cardiology congress presented by the Johns Hopkins University School of Medicine, today announced three new complimentary Continuing Medical Education (CME) Summits to be held over two days on Tuesday June 28th and Wednesday June 29th offering topics of interest to cardiovascular care and internal medicine and family care physicians in Atrial Fibrillation, Interventional Cardiology and Lipids. The Atrial Fibrillation Summit at CardioCareLive is supported by educational grants from Bristol-Myers Squibb and Pfizer, Inc. and Boehringer Ingelheim, the Interventional Cardiology Summit is supported by an educational grant from Daiichi/Lilly and the Lipids Summit at CardioCareLive is supported by an educational grant from Merck & Co.

The Cardiovascular Research Foundation is joining Johns Hopkins in presenting four sessions within the Interventional Cardiology Summit beginning at 2:00 PM EDT on Tuesday June 28th. The Cardiovascular Research Foundation's mission is to improve the survival and quality of life for people with cardiovascular disease through research and education.

CardioCareLive enables physicians, nurse practitioners and physician assistants and other healthcare practitioners to stay current on advances in cardiovascular care at no cost by viewing streaming video CME presentations featuring recognized cardiology experts from the convenience of any computer. A total of 12 AMA PRA Category I Credits will be available during the live programming June 28th and June 29th in addition to the 13 AMA PRA Category I Credits currently available on demand in enduring format at CardioCareLive. It is complimentary to register and attend any program at CardioCareLive.

Physicians from the nation's most respected teaching hospitals and cardiology care associations will act as activity directors for the three programs over two days at CardioCareLive. Dr. Roger Blumenthal, Professor of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, will be the Activity Director for the Atrial Fibrillation, Interventional Cardiology and Lipids Summits. He will be joined by Dr. Gregg Stone, Professor of Medicine at Columbia University College of Physicians and Surgeons, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital/Columbia University Medical Center, and Co-Director of the Medical Research and Education Division at the Cardiovascular Research Foundation, as activity director for the Interventional Cardiology summit. Dr. Chris Cannon, Associate Professor of Medicine at Harvard Medical School and Associate Physician, Cardiovascular Division at Brigham and Women's Hospital, will join Dr. Roger Blumenthal as Activity Director for the Atrial Fibrillation and Lipids summits.

Live programming begins on Tuesday June 28th at 9:00 AM EDT and again on Wednesday June 29th at 11:00 AM EDT, with individual presentations beginning on the hour. Practitioners who attend live may take advantage of interactive capabilities by texting in questions to be addressed live -online by presenting faculty. Each session will be available in on demand (enduring) format as soon as the session concludes. The agenda features the following topics:

Are We Getting Better at Identifying AF Patients at High Risk of Stroke?
Stroke Prevention in AF: Putting the Current Guidelines Into Clinical Practice
New Frontiers in Stroke Prevention in the AF Setting: A Focus on Unmet Patients' Needs
Optimizing Therapy Choices to Prevent Stroke in Patients With AF

In partnership with the Cardiovascular Research Foundation
Clinical Perspectives in Stent Thrombosis: A Focus on Prevention and Management
Optimizing Performance Measures to Improve STEMI Outcomes Syndromes
Who Is at Risk of Antiplatelet Resistance: From Genetics to Clinical Relevance
Stents in Patients With Stable Angina: Overused or Misunderstood?

Optimizing Current Strategies with Statins: A Focus on New Evidence
Moving Beyond Statin Treatment in Dyslipidemias
Emerging Therapies and Their Role in Comprehensive Lipid Management
Management of Residual Cardiovascular Risk


Contact: Judy Romero
Cardiovascular Research Foundation

Related medicine news :

1. Women More Likely to Fail Treatment for Atrial Fibrillation
2. In Tests, Implanted Monitor Detects Atrial Fibrillation
3. Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation
4. People with diabetes are at higher risk of atrial fibrillation
5. BioSTARTM device achieves 90 percent closure rate for atrial septal defect in children
6. Having Relative With Atrial Fibrillation Raises Own Risk
7. New trial studies link between stroke and atrial fibrillation
8. Heavy Drinking May Boost Risk for Atrial Fibrillation
9. Blood Pressure Drug Does Not Help Those With Atrial Fibrillation
10. Data evaluates rehospitalization and cost burden of AFib/atrial flutter
11. Cryoablation used to successfully treat atrial fibrillation at the Montreal Heart Institute
Post Your Comments:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
Breaking Medicine Technology: